1. Immunology/Inflammation Cytoskeleton
  2. CD22 NOD-like Receptor (NLR) Interleukin Related Integrin
  3. Suciraslimab

Suciraslimab  (Synonyms: 舒西利单抗; SM03)

目录号: HY-P990781 纯度: 97.42%
COA 技术支持

Suciraslimab (SM03) 是一种抗人 CD22 单克隆抗体。Suciraslimab 抑制 NLRP3ASC 信号。Suciraslimab 抑制细胞因子 (IL-1βIL-12IL-23) 分泌、α4 integrin 的表达。Suciraslimab 改善工作记忆和神经炎症。Suciraslimab 的同型对照产品:Human IgG1 kappa, Isotype Control (HY-P99001)。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

CAS No. : 2415439-63-1

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
1 mg ¥3000
In-stock
5 mg 现货 询价
10 mg 现货 询价
50 mg   询价  
100 mg   询价  

* Please select Quantity before adding items.

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Suciraslimab (SM03) is an anti-human CD22 monoclonal antibody. Suciraslimab inhibits NLRP3 and ASC signaling. Suciraslimab suppresses cytokine (IL-1β, IL-12, IL-23) secretion and α4 integrin expression. Suciraslimab improves working memory and neuroinflammation[1]. Suciraslimab isotype control product: Human IgG1 kappa, Isotype Control (HY-P99001).

同型

Human IgG1 kappa

推荐同型对照抗体
反应种属

Human

IC50 & Target[1]

IL-23

 

IL-12

 

IL-1β

 

体外研究
(In Vitro)

Suciraslimab (0.1 μg/mL;过夜) 可抑制人单核细胞衍生的小胶质细胞样细胞 (MDMi) 和外周血单个核细胞 (PBMC) 中由 Amyloid β (Aβ) 诱导的白介素-1β (IL-1β) 分泌[1]
Suciraslimab (0.1 μg/mL;4 h) 可增强人小胶质细胞系 HMC-3 和 Phorbol 12-myristate 13-acetate (HY-18739) 分化的人少突胶质细胞系 MO3.13 对 FITC-Aβ 的吞噬作用[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Suciraslimab (15 mg/kg;静脉注射;每周一次) 可缓解人 CD22 转基因小鼠中 Aβ 诱导的神经炎症[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Human CD22 transgenic mice (C57BL/6JGpt-Cd22em1Cin(hCD22)/Gpt), male, 6-9 months old, with intracerebroventricular injection of oligomeric Aβ to induce neuroinflammation[1]
Dosage: 15 mg/kg
Administration: Intravenous injection; once a week
Result: Restored spatial working memory.
Downregulated the expression of genes related to leukocyte migration and sialic acid binding in the brain.
Reduced the levels of chemokines such as CX3CL1, CCL24, and CCL4 in the cortex.
Clinical Trial
基因 ID

933  [NCBI]

Accession
应用

ELISA, FACS, Functional assay

偶联物

Unconjugated

复溶方法

The product can be reconstituted/diluted with sterile PBS or saline.

分子量

146.16 kDa

CAS 号
性状

液体

颜色

Colorless to light yellow

中文名称

舒西利单抗

运输条件

Shipping with dry ice.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

Format
  • IgG1-kappa
Biological Activity
  • Flow Cytometry analysis of Raji cells labelling Siglec-2/CD22 (red) with Suciraslimab (anti-Siglec-2/CD22) (HY-P990781). Goat Anti-Human IgG (Alexa Fluor 488) (HY-P83776) at a dilution of 1/1000 was used as the secondary antibody. Blue-Human IgG1 kappa (HY-P99001). Black-Unlabelled control, cells without incubation with primary antibody.
  • Immobilized Siglec-2/CD22 Protein, Human can bind Suciraslimab. The EC50 for this effect is 4.412 ng/mL.
纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Suciraslimab
目录号:
HY-P990781
需求量: